Literature DB >> 16955947

MRSA: We can overcome, but who will lead the battle?

Margreet C Vos, Henri A Verbrugh.   

Abstract

Mesh：

Year:  2005        PMID： 16955947     DOI： 10.1086/503507

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


× No keyword cloud information.
  3 in total

Review 1.  Transmission rates, screening methods and costs of MRSA--a systematic literature review related to the prevalence in Germany.

Authors:  A Tübbicke; C Hübner; A Kramer; N-O Hübner; S Fleßa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-05-10       Impact factor: 3.267

2.  Activity of the extracts and neolignans from Piper regnellii against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Flaviano João Basilio Marçal; Diógenes Aparício Garcia Cortez; Tânia Ueda-Nakamura; Celso Vataru Nakamura; Benedito Prado Dias Filho
Journal:  Molecules       Date:  2010-03-24       Impact factor: 4.411

3.  Cost comparison of MRSA screening and management - a decision tree analysis.

Authors:  Andrea Tübbicke; Claudia Hübner; Nils-Olaf Hübner; Christian Wegner; Axel Kramer; Steffen Fleßa
Journal:  BMC Health Serv Res       Date:  2012-12-01       Impact factor: 2.655
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.